Feifei Song
London, ENG SW36JB, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.
Journal: Oncogene
Published: June 17, 2024
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors.
Journal: Cancer research
Published: November 16, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
Journal: Molecular oncology
Published: May 11, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells.
Journal: Cell reports
Published: September 02, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
Journal: Cancer research
Published: December 21, 2021
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.
Journal: Communications biology
Published: June 22, 2021
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets.
Journal: Nature communications
Published: November 03, 2017
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
Journal: Nature communications
Published: September 29, 2017
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.
Journal: Cancer discovery
Published: May 30, 2017
Myosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation.
Journal: Nature cell biology
Published: January 05, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026